Business Context and Reporting Period
This Form 8-K reports on events occurring on December 4, 2017, specifically the 2017 Annual Meeting of Stockholders for DarioHealth Corp. The filing details the results of shareholder votes and the adoption of an amendment to the company's equity incentive plan.
Key Financial Metrics
This filing is a current report regarding corporate governance and equity matters. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Corporate Actions
- Equity Incentive Plan Amendment: Shareholders approved an amendment to the Amended and Restated 2012 Equity Incentive Plan. The number of shares authorized for issuance was increased by 1,500,000 shares, raising the total from 2,373,000 to 3,873,000 shares.
- Private Placement Conversion: Shareholders approved the conversion of 2,307,654 shares of Series B Convertible Preferred Stock into an equal number of common shares at a conversion price of $1.80 per share. Additionally, 138,459 shares of common stock were issued to represent a 6% fixed dividend payable upon conversion.
- Director Elections: All eight director nominees were elected. Notably, Yossi Bahagon received a significant number of withheld votes (139,419) compared to other nominees, though he was still elected.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The primary focus is on the ratification of auditors (Kost Forer Gabbay & Kasierer) and the approval of executive compensation advisory votes.
Key Facts for Investor Verification
- Verify the impact of the 1,500,000 share increase in the equity incentive plan on potential future dilution.
- Confirm the final share count following the conversion of 2,307,654 Series B Preferred shares and the issuance of dividend shares.
- Review the voting results for Director Yossi Bahagon, who faced significantly higher opposition (withheld votes) than other board members.
- Note that the company is classified as an Emerging Growth Company.